![Phillips N. Dee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Phillips N.
Dee is Co-Founder of Good Buddy's Coffee Express, Inc. He was a Director of Good Buddy's Coffee Express until July 16, 2008.
Previously, he served in the United States Army as an Armor Officer.
He was President of Atlantic Stone & Timber, Inc. and Patriot, Inc. Mr. Dee received a BA degree in Geography and an MA degree in Economic Geography from the University of North Carolina.
Ehemalige bekannte Positionen von Phillips N. Dee
Unternehmen | Position | Ende |
---|---|---|
RegenoCELL Therapeutics, Inc.
![]() RegenoCELL Therapeutics, Inc. BiotechnologyHealth Technology RegenoCELL Therapeutics, Inc. develops a stem-cell therapy business for the treatment of congestive heart failure and peripheral artery disease. It utilizes adult stem cells, derived from the patient's own blood, which eliminates the ethical and safety concerns associated with embryonic and umbilical cord blood stem cells. The stem cell therapy is either delivered through a catheter or injected directly into the myocardium. The company was founded by Scott Massey on February 1, 2002 and is headquartered in Natick, MA. | Direktor/Vorstandsmitglied | 16.07.2008 |
Ausbildung von Phillips N. Dee
The University of North Carolina at Charlotte | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
RegenoCELL Therapeutics, Inc.
![]() RegenoCELL Therapeutics, Inc. BiotechnologyHealth Technology RegenoCELL Therapeutics, Inc. develops a stem-cell therapy business for the treatment of congestive heart failure and peripheral artery disease. It utilizes adult stem cells, derived from the patient's own blood, which eliminates the ethical and safety concerns associated with embryonic and umbilical cord blood stem cells. The stem cell therapy is either delivered through a catheter or injected directly into the myocardium. The company was founded by Scott Massey on February 1, 2002 and is headquartered in Natick, MA. | Health Technology |